glp 1 agonists mechanism of action Frontiers Mechanisms of GLP-1 Receptor Agonist-Induced

Diabetes 63(12):41864196 Baggio LL, Drucker DJ (2014) Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight

It specifically favors fatty acid oxidation and inhibits nuclear factor kappa B signaling 26

Expert Rev Clin Pharmacol (2017) 10(4):4018

In the Study of Tirzepatide in Participants with Heart Failure with Preserved Ejection Fraction with Obesity (SUMMIT) trial, tirzepatide significantly reduced the risk of death from cardiovascular causes or worsening heart failure events in patients with heart failure with preserved ejection fraction (ejection fraction 50% and above) and obesity (BMI 30 kg/m 2 ), compared with placebo (HR 0.62

Months 6 to 12 and beyond: maximum results and maintenance The STEP trials showed that semaglutide 2.4 mg produces an average of approximately 15% body weight loss by week 68, roughly 16 months

6% of patients from the matched cohort